In a systematic review and meta-analysis by Cui et al., 3,094,152 DM patients were analyzed, and results showed no significant association between PCa and metformin, sulfonylureas (SUs), thiazolidinediones (TZDs), dipeptidyl peptidase-4 inhibitors (DPP4-is), or insulin. The gene discussed is INS; the disease is diabetes mellitus.